Wells Fargo’s Yield10 Bioscience, Inc. Common Stock YTEN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-3
| Closed | -$31 | – | 7715 |
|
|
2024
Q1 | $31 | Buy |
3
+1
| +50% | +$6 | ﹤0.01% | 6982 |
|
|
2023
Q4 | $9 | Sell |
2
-1
| -33% | -$7 | ﹤0.01% | 7418 |
|
|
2023
Q3 | $22 | Buy |
3
+2
| +200% | +$50 | ﹤0.01% | 7173 |
|
|
2023
Q2 | $78 | Hold |
1
| – | – | ﹤0.01% | 6933 |
|
|
2023
Q1 | $77 | Hold |
1
| – | – | ﹤0.01% | 6997 |
|
|
2022
Q4 | $45 | Hold |
1
| – | – | ﹤0.01% | 7049 |
|
|
2022
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 7624 |
|
|
2022
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 7735 |
|
|
2022
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 8066 |
|
|
2021
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 8013 |
|
|
2021
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 7696 |
|
|
2021
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 7632 |
|
|
2021
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 7556 |
|
|
2020
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 7189 |
|
|
2020
Q3 | $0 | Buy |
+1
| New | +$148 | ﹤0.01% | 7077 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 6988 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 6984 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 6837 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 6812 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 6686 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 6556 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 6672 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 6638 |
|
|
2018
Q2 | – | Hold |
0
| – | – | – | 6642 |
|
|
2018
Q1 | – | Hold |
0
| – | – | – | 6627 |
|
|
2017
Q4 | – | Hold |
0
| – | – | – | 6583 |
|
|
2017
Q3 | – | Hold |
0
| – | – | – | 6522 |
|
|
2017
Q2 | – | Hold |
0
| – | – | – | 6510 |
|
|
2017
Q1 | – | Hold |
0
| – | – | – | 6566 |
|
|
2016
Q4 | – | Hold |
0
| – | – | – | 6494 |
|
|
2016
Q3 | – | Hold |
0
| – | – | – | 6392 |
|
|
2016
Q2 | – | Hold |
0
| – | – | – | 6390 |
|
|
2016
Q1 | – | Hold |
0
| – | – | – | 6499 |
|
|
2015
Q4 | – | Hold |
0
| – | – | – | 6474 |
|
|
2015
Q3 | – | Hold |
0
| – | – | – | 6515 |
|
|
2015
Q2 | – | Hold |
0
| – | – | – | 6270 |
|
|
2015
Q1 | – | Hold |
0
| – | – | – | 6086 |
|
|
2014
Q4 | – | Hold |
0
| – | – | – | 6468 |
|
|
2014
Q3 | – | Hold |
0
| – | – | – | 6103 |
|
|
2014
Q2 | – | Hold |
0
| – | – | – | 6033 |
|
|
2014
Q1 | – | Hold |
0
| – | – | – | 5796 |
|
|
2013
Q4 | – | Hold |
0
| – | – | – | 5647 |
|
|
2013
Q3 | – | Hold |
0
| – | – | – | 5553 |
|
|
2013
Q2 | – | Hold |
0
| – | – | – | 5397 |
|
Wells Fargo's YTEN Position: Q2 2024 in Review
Wells Fargo sold out of Yield10 Bioscience, Inc. Common Stock (YTEN) in Q2 2024, closing a stake of 3 shares — an estimated $31 sold.
Wells Fargo first reported a position in YTEN in Q3 2020 and held it in 15 quarters. The position peaked at $78 in Q2 2023. 0 funds tracked by Wall St. Rank hold YTEN as of Q2 2024.
- Wells Fargo reported no remaining Yield10 Bioscience, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
- Wells Fargo sold 3 Yield10 Bioscience, Inc. Common Stock shares in Q2 2024, an estimated $31.
- Wells Fargo first reported a position in Yield10 Bioscience, Inc. Common Stock in Q3 2020 and held it in 15 quarters.
- Wells Fargo's Yield10 Bioscience, Inc. Common Stock position peaked at $78 in Q2 2023.
- 0 funds tracked by Wall St. Rank held Yield10 Bioscience, Inc. Common Stock as of Q2 2024.
Based on Wells Fargo's 13F filing for Q2 2024, filed 13 Aug 2024.